ERIBULIN
Manner of administration:Injection
Restriction (Streamlined authority code: 4649)
Indication: Locally advanced or metastatic breast cancer
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 3 mg | # of repeats: 13 | DPMA: $631.06 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Eribulin Dr.Reddy's
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
| Halaven
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 4649)
Indication: Locally advanced or metastatic breast cancer
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 3 mg | # of repeats: 13 | DPMA: $578.58 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Eribulin Dr.Reddy's
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
| Halaven
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 7258)
Indication: Advanced (unresectable and/or metastatic) liposarcoma
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 7280)
Indication: Advanced (unresectable and/or metastatic) liposarcoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 3 mg | # of repeats: 7 | DPMA: $631.06 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Eribulin Dr.Reddy's
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
| Halaven
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 7258)
Indication: Advanced (unresectable and/or metastatic) liposarcoma
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 7280)
Indication: Advanced (unresectable and/or metastatic) liposarcoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 3 mg | # of repeats: 7 | DPMA: $578.58 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Eribulin Dr.Reddy's
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||
| Halaven
(eribulin mesilate 1 mg/2 mL injection, 2 mL vial)
|
||||